gms | German Medical Science

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2023)

24. - 27.10.2023, Berlin

Midterm results of high-dose-rate intraoperative Brachy-therapy in the treatment of soft tissue sarcomas

Meeting Abstract

Suche in Medline nach

  • presenting/speaker Dietmar Dammerer - UK Krems, Krems, Austria
  • Johannes Neugebauer - UK Krems, Krems, Austria; UK Innsbruck, Innsbruck, Austria

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2023). Berlin, 24.-27.10.2023. Düsseldorf: German Medical Science GMS Publishing House; 2023. DocAB52-2027

doi: 10.3205/23dkou249, urn:nbn:de:0183-23dkou2498

Veröffentlicht: 23. Oktober 2023

© 2023 Dammerer et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objectives: According to the literature only sparse data are available on the use of high-dose-rate intraopera-tive brachytherapy (IOHDR-BT) as an adjuvant boost to external-beam irradiation (EBRT) in combination with a wide resection in patients with high-grade soft tissue sarcomas (STS). With the presentation of our data we would like to make a contribution to show treatment methods and their results.

Methods: Applying a retrospective study design, we investigated all patients who between 2010 and 2016 underwent marginal resection of a high-grade STS and intraoperative radiotherapy, followed by EBRT. We included only patients with a traceable follow-up time of at least two years. Of 89 patients, 35 met our inclusion criteria and showed an average follow-up of four years.

Results: We found an overall 2-year local control rate of 94.3%. The local recurrence rate for R0 resections was 6%, whereas recurrences occurred in 13% of R1 resections and in 100% of R2 resections. One affected patient received only intraoperative radiotherapy. Thus, the recurrence rate by tumor entity was 36% for LPS, 11% for myxofibrosarcoma and 17% for undifferentiated pleomorphic sarcoma.

Conclusion: The treatment regimen consisting of limb-preserving surgery, IORT and pre- or postoperative radiotherapy consistently shows excellent local control rates.